Guideline summary: Appropriate use of tigecycline

  • A J Brink
  • D Bizos Wits
  • K D Boffard Wits
  • C Feldman Wits
  • D C Grolman Wits
  • J Pretorius Wits
  • G A Richards Wits
  • E Steyn


Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs). This article serves as a summary of the guideline on the appropriate use of tigecycline, published in mid-2010 as a collaborative effort by representatives of the Association of Surgeons of South Africa, the Critical Care Society of Southern Africa, the Federation of Infectious Diseases Societies of Southern Africa, the South African Thoracic Society and the Trauma Society of South Africa
How to Cite
Brink, A., Bizos, D., Boffard, K., Feldman, C., Grolman, D., Pretorius, J., Richards, G., & Steyn, E. (2012). Guideline summary: Appropriate use of tigecycline. South African Journal of Surgery, 50(1), 20-21.